Additional evidence supporting this idea is that inhibition of PI3K/AKT and MEK/ERK pathways both enhance the activation of FOXO transcription factors in pancreatic cancer cells (Roy et al., 2010). The gene discussed is AKT1; the disease is pancreatic neoplasm.